Manning & Napier Advisors LLC Sells 13,524 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

Manning & Napier Advisors LLC decreased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 4.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 304,417 shares of the company’s stock after selling 13,524 shares during the period. Manning & Napier Advisors LLC’s holdings in Takeda Pharmaceutical were worth $4,030,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in TAK. FMR LLC increased its holdings in Takeda Pharmaceutical by 10.9% in the third quarter. FMR LLC now owns 2,908,918 shares of the company’s stock valued at $41,365,000 after purchasing an additional 286,052 shares during the last quarter. Van ECK Associates Corp increased its stake in shares of Takeda Pharmaceutical by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,175,236 shares of the company’s stock valued at $30,149,000 after acquiring an additional 134,407 shares during the last quarter. Managed Asset Portfolios LLC increased its stake in shares of Takeda Pharmaceutical by 0.3% in the 3rd quarter. Managed Asset Portfolios LLC now owns 1,617,541 shares of the company’s stock valued at $23,001,000 after acquiring an additional 4,069 shares during the last quarter. Stifel Financial Corp raised its position in shares of Takeda Pharmaceutical by 103.9% in the 3rd quarter. Stifel Financial Corp now owns 440,666 shares of the company’s stock valued at $6,266,000 after acquiring an additional 224,594 shares during the period. Finally, Pathstone Holdings LLC boosted its stake in Takeda Pharmaceutical by 1.0% during the 3rd quarter. Pathstone Holdings LLC now owns 430,676 shares of the company’s stock worth $6,124,000 after acquiring an additional 4,280 shares during the last quarter. Institutional investors and hedge funds own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Down 0.2 %

Shares of NYSE:TAK opened at $13.35 on Thursday. The company has a 50 day moving average price of $13.30 and a two-hundred day moving average price of $13.89. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28. The company has a market capitalization of $42.46 billion, a PE ratio of 23.01, a PEG ratio of 0.24 and a beta of 0.51. Takeda Pharmaceutical Company Limited has a 52 week low of $12.57 and a 52 week high of $15.08.

Takeda Pharmaceutical Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.